145 related articles for article (PubMed ID: 38319415)
1. Deciphering the heterogeneity of neutrophil cells within circulation and the lung cancer microenvironment pre- and post-operation.
Liu F; Liu X; Liu Y; Chen D; Liu X; Qin C; Song Y; Fang H; Wu D
Cell Biol Toxicol; 2024 Feb; 40(1):11. PubMed ID: 38319415
[TBL] [Abstract][Full Text] [Related]
2. Integrating Single-cell RNA-seq to construct a Neutrophil prognostic model for predicting immune responses in non-small cell lung cancer.
Pang J; Yu Q; Chen Y; Yuan H; Sheng M; Tang W
J Transl Med; 2022 Nov; 20(1):531. PubMed ID: 36401283
[TBL] [Abstract][Full Text] [Related]
3. Cellular dynamics in tumour microenvironment along with lung cancer progression underscore spatial and evolutionary heterogeneity of neutrophil.
Peng H; Wu X; Liu S; He M; Tang C; Wen Y; Xie C; Zhong R; Li C; Xiong S; Liu J; Zheng H; He J; Lu X; Liang W
Clin Transl Med; 2023 Jul; 13(7):e1340. PubMed ID: 37491740
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil infiltration associated genes on the prognosis and tumor immune microenvironment of lung adenocarcinoma.
Liu R; Zhu G; Sun Y; Li M; Hu Z; Cao P; Li X; Song Z; Chen J
Front Immunol; 2023; 14():1304529. PubMed ID: 38204755
[TBL] [Abstract][Full Text] [Related]
5. Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing.
Hu J; Zhang L; Xia H; Yan Y; Zhu X; Sun F; Sun L; Li S; Li D; Wang J; Han Y; Zhang J; Bian D; Yu H; Chen Y; Fan P; Ma Q; Jiang G; Wang C; Zhang P
Genome Med; 2023 Mar; 15(1):14. PubMed ID: 36869384
[TBL] [Abstract][Full Text] [Related]
6. Molecular profiling of human non-small cell lung cancer by single-cell RNA-seq.
Li Q; Wang R; Yang Z; Li W; Yang J; Wang Z; Bai H; Cui Y; Tian Y; Wu Z; Guo Y; Xu J; Wen L; He J; Tang F; Wang J
Genome Med; 2022 Aug; 14(1):87. PubMed ID: 35962452
[TBL] [Abstract][Full Text] [Related]
7. Yi Qi Chu Tan Formula (YQCTF) inhibited the progress of lung cancer via regulating tumor-associated neutrophil: An integrated study of network pharmacology, proteomics and pharmacodynamics.
Le-Xin C; Ming-Jun L; Chun-Qi X; Jia-Xin Z; Jing-Ya Y; Li-Xin N; Mei-Qi W; En-Xin Z; Xiao-Jun Z
J Ethnopharmacol; 2024 Jan; 318(Pt B):116943. PubMed ID: 37532072
[TBL] [Abstract][Full Text] [Related]
8. HER-2/neu protein expression and gene alteration in stage I-IIIA non-small-cell lung cancer: a study of 140 cases using a combination of high throughput tissue microarray, immunohistochemistry, and fluorescent in situ hybridization.
Tan D; Deeb G; Wang J; Slocum HK; Winston J; Wiseman S; Beck A; Sait S; Anderson T; Nwogu C; Ramnath N; Loewen G
Diagn Mol Pathol; 2003 Dec; 12(4):201-11. PubMed ID: 14639106
[TBL] [Abstract][Full Text] [Related]
9. The value of red blood cell distribution width, neutrophil-to-lymphocyte ratio, and hemoglobin-to-red blood cell distribution width ratio in the progression of non-small cell lung cancer.
Chen JL; Wu JN; Lv XD; Yang QC; Chen JR; Zhang DM
PLoS One; 2020; 15(8):e0237947. PubMed ID: 32833961
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq data reveals dynamic changes in tumor-associated neutrophils in the tumor microenvironment of hepatocellular carcinoma and leads to the establishment of a neutrophil-related prognostic model.
Yang D; Zhou Y; Zhang Y; Su Y; Shen J; Yu B; Zhao K; Ding Y
Cancer Immunol Immunother; 2023 Dec; 72(12):4323-4335. PubMed ID: 38006433
[TBL] [Abstract][Full Text] [Related]
11. Tumor-infiltrating neutrophils and peripheral neutrophil-to-lymphocyte ratio conversely predicted the prognosis of patients with non-small cell lung cancer.
Yang R; Wang X; Ma C; Zhang Z; Liu N; Ma X; Zhang Y; Wang X; Liu Y
Cell Immunol; 2022 Sep; 379():104588. PubMed ID: 35961201
[TBL] [Abstract][Full Text] [Related]
12. Single-Cell RNA Sequencing Reveals the Heterogeneity of Tumor-Associated Macrophage in Non-Small Cell Lung Cancer and Differences Between Sexes.
Yang Q; Zhang H; Wei T; Lin A; Sun Y; Luo P; Zhang J
Front Immunol; 2021; 12():756722. PubMed ID: 34804043
[TBL] [Abstract][Full Text] [Related]
13. Harnessing neutrophil plasticity for HCC immunotherapy.
Ramon-Gil E; Geh D; Leslie J
Essays Biochem; 2023 Sep; 67(6):941-955. PubMed ID: 37534829
[TBL] [Abstract][Full Text] [Related]
14. Identification of the cell cycle characteristics of non-small cell lung cancer and its relationship with tumor immune microenvironment, cell death pathways, and metabolic reprogramming.
Cao S; Xiao S; Zhang J; Li S
Front Endocrinol (Lausanne); 2023; 14():1147366. PubMed ID: 37091844
[TBL] [Abstract][Full Text] [Related]
15. Diversity and heterogeneity of immune states in non-small cell lung cancer and small cell lung cancer.
Rice SJ; Belani CP
PLoS One; 2021; 16(12):e0260988. PubMed ID: 34855926
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil expansion defines an immunoinhibitory peripheral and intratumoral inflammatory milieu in resected non-small cell lung cancer: a descriptive analysis of a prospectively immunoprofiled cohort.
Mitchell KG; Diao L; Karpinets T; Negrao MV; Tran HT; Parra ER; Corsini EM; Reuben A; Federico L; Bernatchez C; Dejima H; Francisco-Cruz A; Wang J; Antonoff MB; Vaporciyan AA; Swisher SG; Cascone T; Wistuba II; Heymach JV; Gibbons DL; Zhang J; Haymaker CL; Sepesi B
J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32350118
[TBL] [Abstract][Full Text] [Related]
17. Low peripheral blood derived neutrophil-to-lymphocyte ratio (dNLR) is associated with increased tumor T-cell infiltration and favorable outcomes to first-line pembrolizumab in non-small cell lung cancer.
Alessi JV; Ricciuti B; Alden SL; Bertram AA; Lin JJ; Sakhi M; Nishino M; Vaz VR; Lindsay J; Turner MM; Pfaff K; Sharma B; Felt KD; Rodig SJ; Gainor JF; Awad MM
J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34824161
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of tumor immune microenvironment in malignant and metastatic change in LUAD is revealed by single-cell RNA sequencing.
Wang H; Han G; Chen J
Aging (Albany NY); 2023 Jun; 15(12):5339-5354. PubMed ID: 37335089
[TBL] [Abstract][Full Text] [Related]
19. Single-cell and spatial transcriptomics reveal POSTN
Chen C; Guo Q; Liu Y; Hou Q; Liao M; Guo Y; Zang Y; Wang F; Liu H; Luan X; Liang Y; Guan Z; Li Y; Liu H; Dong X; Zhang X; Liu J; Xu Q
Clin Transl Med; 2023 Dec; 13(12):e1515. PubMed ID: 38115703
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil-Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non-Small Cell Lung Cancer Treated with Combined Modality Therapy.
Scilla KA; Bentzen SM; Lam VK; Mohindra P; Nichols EM; Vyfhuis MA; Bhooshan N; Feigenberg SJ; Edelman MJ; Feliciano JL
Oncologist; 2017 Jun; 22(6):737-742. PubMed ID: 28533476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
